Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.

Unicycive Therapeutics Inc Is A Clinical-Stage Biotechnology Company Focused On Identifying, Developing, And Commercializing Therapies To Address Unmet Medical Needs, With A Primary Focus On Kidney Disease. The Company Is Advancing Two Key Product Candidates: Oxylanthanum Carbonate (Olc), A Phosphate Binder For The Treatment Of Hyperphosphatemia In Chronic Kidney Disease Patients On Dialysis, And Uni-494, A Drug Candidate For The Treatment Of Acute Kidney Injury.